Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia

Critical Care Medicine

Volumn 40, Issue 9, 2012, Pages 2552-2561

  Ranzani, Otavio Tavares ^a,b,c   Ferrer, Miquel ^a,b   Esperatti, Mariano ^a   Giunta, Valeria ^a,b,d   Bassi, Gianluigi Li ^b   Carvalho, Carlos Roberto Ribeiro ^c   Torres, Antoni ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

bacterial count; corticosteroids; intensive care unit acquired pneumonia; nosocomial pneumonia; ventilator associated pneumonia

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; PREDNISOLONE; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BACTEREMIA; BACTERIAL LOAD; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG USE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OXYGEN THERAPY; PLEURA EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ADRENAL CORTEX HORMONES; APACHE; CAUSE OF DEATH; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84865478281     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318259203d     Document Type: Article

References (50)

1. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
2. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
3. Esperatti M, Ferrer M, Theessen A, et al: Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med 2010; 182:1533-1539
4. Fagon JY, Chastre J, Hance AJ, et al: Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
5. Heyland DK, Cook DJ, Griffith L, et al: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159(4 Pt 1):1249-1256
6. Kollef MH: Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: A perspective from academia. Clin Infect Dis 2010; 51 Suppl 1:S29-S35
7. Nseir S, Di Pompeo C, Soubrier S, et al: Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005; 128:1650-1656
8. Niederman MS: Can optimal management prevent mortality in ventilator-associated pneumonia? Crit Care Med 2002; 30:1916-1917
9. Marik PE, Meduri GU, Rocco PR, et al: Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin 2011; 27:589-607
10. Alderson P, Roberts I: Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev 2005; CD000196
11. Marik PE: Glucocorticoids in sepsis: Dissecting facts from fiction. Crit Care 2011; 15:158
12. Rady MY, Johnson DJ, Patel B, et al: Corticosteroids influence the mortality and morbidity of acute critical illness. Crit Care 2006; 10:R101
13. Giantsou E, Liratzopoulos N, Efraimidou E, et al: Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med 2005; 31:1488-1494
14. Beale R, Janes JM, Brunkhorst FM, et al: Global utilization of low-dose corticosteroids in severe sepsis and septic shock: A report from the PROGRESS registry. Crit Care 2010; 14:R102
15. Cook DJ, Kollef MH: Risk factors for ICU-acquired pneumonia. JAMA 1998; 279:1605-1606
16. Roquilly A, Mahe PJ, Seguin P, et al: Hydrocortisone therapy for patients with multiple trauma: The randomized controlled HYPOLYTE study. JAMA 2011; 305:1201-1209
17. Edis EC, Hatipoglu ON, Tansel O, et al: Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents. Ann Thorac Med 2010; 5:92-96
18. Montón C, Ewig S, Torres A, et al: Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: A pilot study. Eur Respir J 1999; 14:218-220
19. Ioanas M, Ferrer M, Cavalcanti M, et al: Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med 2004; 32:938-945
20. Gursel G, Aydogdu M, Ozyilmaz E, et al: Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy. J Crit Care 2008; 23:34-40
21. Agustí C, Rañó A, Filella X, et al: Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: Etiology, prognostic factors, and associated inflammatory response. Chest 2003; 123:488-498
22. Fàbregas N, Ewig S, Torres A, et al: Clinical diagnosis of ventilator associated pneumonia revisited: Comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54:867-873
23. Luna CM, Blanzaco D, Niederman MS, et al: Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31:676-682
24. Menéndez R, Martinez R, Reyes S, et al: Stability in community-acquired pneumonia: One step forward with markers? Thorax 2009; 64:987-992
25. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
26. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
27. Dellinger RP, Levy MM, Carlet JM, et al: International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
28. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1): 818-824
29. Laessig KA: End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: Food and drug administration perspective. Clin Infect Dis 2010; 51(Suppl 1):S117-S119
30. Schoenfeld DA, Bernard GR; ARDS Network: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30:1772-1777
31. Joffe MM, Rosenbaum PR: Invited commentary: Propensity scores. Am J Epidemiol 1999; 150:327-333
32. Brun-Buisson C, Richard JC, Mercat A, et al: REVA-SRLF A/H1N1v 2009 Registry Group: Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183:1200-1206
33. Brookhart MA, Schneeweiss S, Rothman KJ, et al: Variable selection for propensity score models. Am J Epidemiol 2006; 163:1149-1156
34. Hosmer D, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989
35. Imai K, van Dyk DA: Causal inference with general treatment regimes. J Am Statist Assoc 2004; 99:854-866
36. Mirsaeidi M, Peyrani P, Aliberti S, et al: Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia. Chest 2010; 137:416-420
37. Napolitano LM: Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010; 51 Suppl 1:S67-S80
38. Alía I, de la Cal MA, Esteban A, et al: Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med 2011; 171:1939-1946
39. Minneci PC, Deans KJ, Eichacker PQ, et al: The effects of steroids during sepsis depend on dose and severity of illness: An updated meta-analysis. Clin Microbiol Infect 2009; 15:308-318
40. Chastre J, Wolff M, Fagon JY, et al: PneumA Trial Group: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588-2598
41. Lacherade JC, De Jonghe B, Guezennec P, et al: Intermittent subglottic secretion drainage and ventilator-associated pneumonia: A multicenter trial. Am J Respir Crit Care Med 2010; 182:910-917
42. Caruso P, Denari S, Ruiz SA, et al: Saline instillation before tracheal suctioning decreases the incidence of ventilator-associated pneumonia. Crit Care Med 2009; 37:32-38
43. Li D, Chen L, Ding X, et al: Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure. BMC Gastroenterol 2008; 8:32
44. Voiriot G, Dury S, Parrot A, et al: Nonsteroidal antiinflammatory drugs may affect the presentation and course of community-acquired pneumonia. Chest 2011; 139:387-394
45. Legras A, Giraudeau B, Jonville-Bera AP, et al: A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock. Crit Care 2009; 13:R43
46. American Thoracic Society: Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1996; 153:1711-1725
47. Ramírez P, Ferrer M, Gimeno R, et al: Systemic inflammatory response and increased risk for ventilator-associated pneumonia: A preliminary study. Crit Care Med 2009; 37:1691-1695
48. Sibila O, Luna CM, Agustí C, et al: Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J 2008; 32:1037-1046
49. Eichacker PQ, Parent C, Kalil A, et al: Risk and the efficacy of antiinflammatory agents: Retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002; 166:1197-1205
50. Fernández-Serrano S, Dorca J, Garcia-Vidal C, et al: Effect of corticosteroids on the clinical course of community-acquired pneumonia: A randomized controlled trial. Crit Care 2011; 15:R96